Foldamers 2007
DOI: 10.1002/9783527611478.ch8
|View full text |Cite
|
Sign up to set email alerts
|

Biological Applications of Foldamers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 248 publications
0
3
0
Order By: Relevance
“…Thus, one major line of development in foldamer chemistry is the investigation of function; for example, biological activity [2,3] and molecular-recognition properties. [4,5] However, even in nature, isolated secondary structures achieve little function relative to tertiary or quaternary structures.…”
Section: Nicolas Delsucmentioning
confidence: 99%
“…Thus, one major line of development in foldamer chemistry is the investigation of function; for example, biological activity [2,3] and molecular-recognition properties. [4,5] However, even in nature, isolated secondary structures achieve little function relative to tertiary or quaternary structures.…”
Section: Nicolas Delsucmentioning
confidence: 99%
“…[4][5][6][7][8][9][10][11][12][13] Designing molecules with well-defined secondary structures not only contribute towards a better understanding of the structural evolution of biological macromolecules but can also lead to the creation of useful self-assembled architectures for the applications in selective absorption, catalytic activities, transport and separation processes. [14][15][16] A de-novo design of foldamers involves the identification of structural elements which are capable of invoking the higher-order architectures. Although the early work on foldamers involved the use of biotic precursors to mimic higher-order structures in the laboratory environment, the field has been growing rapidly in the last two decades with the discoveries of diverse abiotic structural precursors leading to a variety of applications.…”
Section: Introductionmentioning
confidence: 99%
“…Nonetheless, other foldamer properties have been intensely investigated in recent years, in particular their potential to interfere with biological functions. [4] At first glance, the idea of using synthetic foldamers as potential therapeutic agents is not obvious, because they are generally much larger-typically between 0.5 and 5 kDa-than conventional drugs. However, size can also help solve problems that are hard to tackle with smaller molecules.…”
mentioning
confidence: 99%